Selenium and Oral Mucositis in Head and Neck Cancer Patients
Author Information
Author(s): Laali Elahe, Manifar Soheila, Kazemian Ali, Jahangard-Rafsanjani Zahra, Gholami Kheirollah
Primary Institution: Tehran University of Medical Sciences
Hypothesis
Does selenium supplementation affect the incidence and severity of oral mucositis during radiotherapy in patients with head and neck cancer?
Conclusion
Selenium supplementation does not appear to affect the selenium level as well as the severity and duration of oral mucositis.
Supporting Evidence
- Seventy-one patients with head and neck cancer were enrolled in the study.
- The cumulative incidence of oral mucositis was 97.3% in the selenium group and 100% in the placebo group.
- The mean duration of oral mucositis was not different between the two groups.
Takeaway
This study looked at whether taking selenium could help prevent mouth sores in cancer patients getting radiation treatment, but it didn't seem to make a difference.
Methodology
Patients with head and neck cancer received either selenium or placebo, and the grade of oral mucositis was evaluated weekly using the WHO grading system.
Limitations
Oral selenium supplementation adherence might affect the outcome interpretation.
Participant Demographics
Patients aged 18–85 years with head and neck cancer scheduled for radiation.
Statistical Information
P-Value
0.79
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website